Management of Scalp Folliculitis
For scalp folliculitis, treatment depends on severity: mild cases require only warm compresses, while moderate-to-severe cases need incision and drainage plus systemic antibiotics active against Staphylococcus aureus, with consideration for MRSA coverage based on local resistance patterns and systemic signs of infection. 1
Initial Assessment and Diagnosis
Critical first step: Distinguish bacterial folliculitis from fungal tinea capitis, as management differs fundamentally. 1
- Bacterial folliculitis presents with superficial pustules, inflammatory nodules with overlying pustules through which hair emerges, and pus limited to the epidermis 1
- Tinea capitis (fungal) presents with patchy alopecia, scaling, and may show scattered pustules or low-grade folliculitis with painful regional lymphadenopathy 1
- Obtain cultures (Gram stain and bacterial culture) from pustules or abscesses to guide antibiotic selection and identify MRSA 1
- For suspected tinea capitis, obtain fungal cultures via scalp brushings, hair plucking, or scalpel scraping 1
Treatment Algorithm Based on Severity
Mild Folliculitis (Superficial, Limited Lesions)
- Moist heat application to promote spontaneous drainage 1
- No systemic antibiotics required unless fever or extensive surrounding cellulitis develops 1
- Topical mupirocin or retapamulin may be considered for localized disease 1
Moderate-to-Severe Folliculitis (Multiple Lesions, Furuncles, or Carbuncles)
Incision and drainage is the primary treatment for all furuncles, carbuncles, and abscesses 1
- Simply cover the surgical site with dry dressing (packing not necessary and causes more pain) 1
- Add systemic antibiotics if any of the following present: 1
- SIRS criteria (temperature >38°C or <36°C, tachycardia >90 bpm, tachypnea >24 breaths/min, WBC >12,000 or <4,000 cells/µL)
- Extensive surrounding cellulitis
- Fever or systemic symptoms
- Multiple lesions
- Severely impaired host defenses
Antibiotic Selection
For MSSA (methicillin-susceptible S. aureus): 1
- First-line: Dicloxacillin or cephalexin
- Alternative: Clindamycin 150 mg daily
For MRSA coverage (required if local resistance >10-15% or patient has risk factors): 1
- Trimethoprim-sulfamethoxazole
- Doxycycline or minocycline
- Clindamycin (if susceptible)
- Linezolid (for severe cases)
Duration: 5-10 days for acute infection 1
Recurrent Scalp Folliculitis
For patients with recurrent episodes, implement decolonization strategy: 1
- Intranasal mupirocin ointment twice daily for first 5 days of each month (reduces recurrences by ~50%) 1
- Oral clindamycin 150 mg daily for 3 months for susceptible S. aureus (decreases subsequent infections by ~80%) 1
- Daily chlorhexidine washes of the scalp 1
- Daily decontamination of personal items (towels, sheets, pillowcases) 1
- Culture recurrent lesions early to guide targeted therapy 1
Special Considerations and Pitfalls
Common diagnostic errors to avoid:
- Do not misdiagnose kerion (severe inflammatory tinea capitis) as bacterial abscess - kerion presents as painful, boggy inflammatory mass with pustules and requires systemic antifungal therapy, not just antibiotics 1
- Consider secondary bacterial superinfection in tinea capitis with pustules - may require both antifungal and antibacterial therapy 1
- Folliculitis decalvans is a chronic scarring bacterial folliculitis caused by S. aureus requiring prolonged oral antibiotics (not just short courses) 2, 3, 4
When systemic antibiotics are NOT needed: 1
- Small, isolated furuncles without systemic signs
- Simple inflamed epidermoid cysts (inflammation is chemical, not infectious)
- After adequate incision and drainage in immunocompetent patients without SIRS
Hygiene measures during treatment: 1
- Bathing with chlorhexidine or antibacterial soaps
- Thorough laundering of clothing, towels, and bedding
- Separate use of towels and washcloths
- Avoid manipulation or picking at lesions
For inflammatory tinea capitis variants: Systemic antifungal therapy is mandatory (topical agents alone are insufficient), and oral corticosteroids may be added for severe kerion to reduce scarring risk 1